Zimmer Biomet (ZBH) PT Raised to $150 at BMO Capital
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $100.11 +0.71%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
BMO Capital analyst Joanne Wuensch raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $137.00) while maintaining an Outperform rating.
- On the Recovery Road, Six Months Ahead of Schedule
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- GitLab Inc (GTLB) PT Raised to $55 at TD Cowen
- Palo Alto Networks (PANW) PT Raised to $475 at RBC Capital
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
